HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
90.18
-0.14 (-0.16%)
At close: Mar 25, 2025, 4:00 PM
88.89
-1.28 (-1.43%)
After-hours: Mar 25, 2025, 4:07 PM EST
HealthEquity Revenue
In the fiscal year ending January 31, 2025, HealthEquity had annual revenue of $1.20B with 20.03% growth. HealthEquity had revenue of $311.82M in the quarter ending January 31, 2025, with 18.84% growth.
Revenue (ttm)
$1.20B
Revenue Growth
+20.03%
P/S Ratio
6.53
Revenue / Employee
$380,881
Employees
3,150
Market Cap
7.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 31, 2025 | 1.20B | 200.19M | 20.03% |
| Jan 31, 2024 | 999.59M | 137.84M | 16.00% |
| Jan 31, 2023 | 861.75M | 105.19M | 13.90% |
| Jan 31, 2022 | 756.56M | 22.99M | 3.13% |
| Jan 31, 2021 | 733.57M | 201.58M | 37.89% |
| Jan 31, 2020 | Pro | Pro | Pro |
| Jan 31, 2019 | Pro | Pro | Pro |
| Jan 31, 2018 | Pro | Pro | Pro |
| Jan 31, 2017 | Pro | Pro | Pro |
| Jan 31, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
HQY News
- 17 hours ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against HealthEquity, Inc. (HQY) And Encourages Stockholders to Reach Out - Accesswire
- 1 day ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating HealthEquity, Inc. (HQY) And Encourages Stockholders to Connect - Accesswire
- 2 days ago - HealthEquity, Inc. (HQY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 4 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against HealthEquity, Inc. (HQY) and Encourages Stockholders to Learn More About the Investigation - Accesswire
- 5 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages HealthEquity, Inc. (HQY) Investors to Inquire about Securities Investigation - Accesswire
- 6 days ago - HealthEquity's Long-Term Growth Intact Despite Short-Term Margin Pressures, Analyst Says - Benzinga
- 6 days ago - HealthEquity: Selling Off On Uncertainties - Seeking Alpha
- 6 days ago - Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga